P815 Are hospitalised patients with inflammatory bowel disease at increased risk of invasive bacterial infections? Results from POLIBD 2-year cohort study
ECCO'20 Vienna
2020
P816 Association of autoimmune rheumatic disease with inflammatory bowel disease: a nationwide population-based study
ECCO'20 Vienna
2020
P817 Influence of inflammatory bowel diseases on depression and suicidal risk: a questionnaire-based survey
ECCO'20 Vienna
2020
P818 Venous thromboembolism is rare among hospitalised patients with an inflammatory bowel disease flare: a multicentre retrospective cross-sectional study
ECCO'20 Vienna
2020
P819 Seroprevalence of Borrelia burgdorferi antibodies in patients with ulcerative colitis
ECCO'20 Vienna
2020
P820 An easy and rapid targeted next generation sequencing-based genotyping assay for the validated IBD risk loci
ECCO'20 Vienna
2020
P821 HLADQA1-HLADRB1 pre-emptive screening for azathioprine-induced pancreatitis in inflammatory bowel disease: a preliminary report
ECCO'20 Vienna
2020
P822 Genetic analysis of ulcerative colitis in Japanese individuals using population-specific SNP array
ECCO'20 Vienna
2020
P823 DNA methylation profiles accurately predict vedolizumab response and remain stable during induction and maintenance treatment in Crohn’s disease
ECCO'20 Vienna
2020
P824 Molecular predictors of anti-TNF treatment response in patients with Crohn’s disease
ECCO'20 Vienna
2020
P825 The impact of a SNP-dose–response effect on course of inflammatory bowel disease: a numerical analysis of SNP distribution within the Swiss IBD Cohort Study
ECCO'20 Vienna
2020
P826 A predictive molecular classification developed in UC patients with active disease is observed consistently in a heterogeneous group of IBD patients
ECCO'20 Vienna
2020
P827 The clinical phenotype of collagenous colitis is associated with T-cell-related genetic variants
ECCO'20 Vienna
2020
P828 DNA methylation profile defines epigenetic characteristics and molecular targets of Crohn’s disease
ECCO'20 Vienna
2020
P830 Genotype-based treatment with thiopurine reduces incidence of myelosuppression in patients with inflammatory bowel diseases
ECCO'20 Vienna
2020
P831 The role of adherent-invasive E. coli in pediatric Crohn’s disease: cause or effect?
ECCO'20 Vienna
2020
P832 Gastrointestinal infections are associated with unique gut microbiome signatures in patients with inflammatory bowel disease
ECCO'20 Vienna
2020